Pharma PR Newswire

Pharma Focus Asia offers the most advanced strategies in Pharmaceutical Sector, the most significant developments in the industry and provides information on the latest research in Pharma Healthcare. The following Press Releases highlights the recent happenings in the Pharmaceutical Sector across the world.

Sinovac Reports Unaudited Second Quarter 2016 Financial Results

Tuesday, August 23, 2016 PR Newswire

BEIJING Aug 23 2016 PRNewswire Sinovac Biotech Ltd NASDAQ SVA a leading provider of biopharmaceutical products in China announced today its unaudited second quarter ended June 30 2016 Mr Weidong Yin Chairman President and CEO of the Sinovac commented As forecasted on our first quarter earnings ..

Students Gain Valuable Research Experience Through NJHF $100,000 Grant for Summer Programs

Monday, August 22, 2016 PR Newswire

NEW BRUNSWICK NJ Aug 22 2016 PRNewswireUSNewswire To further its mission of advancing healthrelated educational programs in the state New Jersey Health Foundation NJHF has once again contributed 100000 to fund Student Summer Research Programs at Rowan and Rutgers Universities To date NJHF has con..

Organic Medicine Is Finally Here!

Monday, August 22, 2016 PR Newswire

LOS ANGELES Aug 22 2016 PRNewswire Drugstore News recently reported research about the growth of the natural overthecounter OTC medicine market indicating the market for natural OTCs increased by more than 11 percent in 2015 It reports that the largest category the natural coughcoldimmunity marke..

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2016

Monday, August 22, 2016 PR Newswire

XIANYANG China Aug 22 2016 PRNewswire Biostar Pharmaceuticals Inc NASDAQ BSPM Biostar or the Company a PRCbased manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions today announced its financial results for the second quarter..

Sophiris Bio Announces Proposed Public Offering of Common Shares and Warrants

Monday, August 22, 2016 PR Newswire

SAN DIEGO and VANCOUVER British Columbia Aug 22 2016 PRNewswire Sophiris Bio Inc NASDAQ SPHS Sophiris a biopharmaceutical company developing PRX302 topsalysin for the treatment of urological diseases today announced that it intends to offer and sell subject to market and other conditions its commo..

Kindred Biosciences Submits New Animal Drug Application Technical Section for Effectiveness for Mirataz to FDA

Monday, August 22, 2016 PR Newswire

SAN FRANCISCO Aug 22 2016 PRNewswire Kindred Biosciences Inc NASDAQ KIN a biopharmaceutical company focused on saving and improving the lives of pets today announced the submission of the Effectiveness Technical Section of the New Animal Drug Application for Mirataz mirtazapine transdermal ointme..

PhaseRx Appoints Peggy Phillips to Board of Directors

Monday, August 22, 2016 PR Newswire

SEATTLE Aug 22 2016 PRNewswire PhaseRx Inc NASDAQ PZRX a biopharmaceutical company developing mRNA products to correct lifethreatening inherited liver diseases in children today announced the appointment of Peggy Phillips to the companys board of directors Ms Phillips will be replacing Richard Ul..

China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2017

Monday, August 22, 2016 PR Newswire

HONG KONG Aug 22 2016 PRNewswire China Cord Blood Corporation NYSE CO CCBC or the Company Chinas leading provider of cord blood collection laboratory testing hematopoietic stem cell processing and stem cell storage services today announced its unaudited financial results for the first quarter of ..

Cinven to acquire Bioclinica

Monday, August 22, 2016 PR Newswire

LONDON Aug 22 2016 PRNewswire International private equity firm Cinven today announces that it has agreed to acquire Bioclinica a global provider of clinical trial services and technology to contract research organizations CROs and pharmaceutical companies based in Pennsylvania from Water Str..

Concordia International Corp. Issues Statement On Sale Of Company Stock

Monday, August 22, 2016 PR Newswire

OAKVILLE ON Aug 22 2016 PRNewswire Concordia International Corp Concordia or the Company NASDAQ CXRX TSX CXR an international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs stated that Concordias Chairman and Chief Executive Officer Mark Thompson was notified ear..

Mallinckrodt To Present At Morgan Stanley Global Healthcare Conference

Monday, August 22, 2016 PR Newswire

CHESTERFIELD United Kingdom Aug 22 2016 PRNewswire Mallinckrodt Pharmaceuticals NYSE MNK a leading global specialty pharmaceutical company will present on Monday Sept 12 2016 at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt New York 109 E 42nd St New York Mark Trudeau Presi..

Research Report Initiation on Biotech Stocks -- PTC Therapeutics, Grifols, Puma Biotech, and 22nd Century

Monday, August 22, 2016 PR Newswire

NEW YORK August 22 2016 PRNewswire StockCallerscom today has issued research reports on PTC Therapeutics Inc NASDAQ PTCT Grifols SA NASDAQ GRFS Puma Biotechnology Inc NYSE PBYI and 22nd Century Group Inc NYSE MKT XXII These stocks belong in the Biotech arena which over the recent weeks has slowl..

BioRx Releases Next-Generation MyFactor® App for iOS and Android

Monday, August 22, 2016 PR Newswire

CINCINNATI Aug 22 2016 PRNewswire BioRx a Diplomat company NYSE DPLO announced today the release of its newest version of the MyFactor app for iOS and Android mobile devices The new versions of the app are available for download on the App Store and Google Play MyFactor enables hemophilia patien..

MabVax Therapeutics Announces the Closing of its Public Offering

Monday, August 22, 2016 PR Newswire

SAN DIEGO Aug 22 2016 PRNewswire MabVax Therapeutics Holdings Inc Nasdaq MBVX a clinicalstage oncology drug development company announces the closing of its public offering of common stock and Series F Preferred Stock and warrants for a total of 94 million including approximately 800000 received f..

Lycera Announces Initiation of Phase 2 Clinical Trial of LYC-30937-EC in Patients with Ulcerative Colitis

Monday, August 22, 2016 PR Newswire

NEW YORK and ANN ARBOR Mich Aug 22 2016 PRNewswire Lycera Corp a privately held biopharmaceutical company developing breakthrough immune modulatory medicines announced today the initiation of a Phase 2 clinical trial of the Companys lead clinicalstage candidate LYC30937Enteric Coated in patients w..

Janssen Announces 25 Presentations at Upcoming ESC Congress 2016, Including New Clinical and Real-World Research on XARELTO® and Latest Findings from REVISIT-US

Monday, August 22, 2016 PR Newswire

RARITAN NJ Aug 22 2016 PRNewswire Janssen Pharmaceuticals Inc today announced that 25 abstracts have been accepted for presentation by Janssen and its development partner Bayer at the ESC Congress 2016 taking place August 2731 in Rome Italy New realworld evidence from the EXPLORER research progra..

Ateb Expands Its Raleigh Headquarters

Monday, August 22, 2016 PR Newswire

RALEIGH NC Aug 22 2016 PRNewswire Ateb Inc the industrys leading provider of pharmacybased patient care solutions completes the expansion of its Raleigh Headquarters as a result of the companys continued growth Generating an additional 25 percent growth in the companys overall head count in the ..

Richard A. Bierly Appointed to Impax Laboratories Board of Directors

Monday, August 22, 2016 PR Newswire

HAYWARD Calif Aug 22 2016 PRNewswire Impax Laboratories Inc NASDAQ IPXL announcedtoday that Richard A Bierly was appointed to the Impax Board of Directors on August 19 and will also serve on the Boards Audit Committee Mr Bierly 61 was most recently the Chief Financial Officer of Medivation Inc L..

BioPharmX Announces Final Phase 2a Trial Results Find BPX-01 Reduces Facial P. Acnes by More than 90% in Four Weeks

Monday, August 22, 2016 PR Newswire

MENLO PARK Calif Aug 22 2016 PRNewswire BioPharmX Corporation NYSE MKT BPMX a specialty pharmaceutical company developing products for the dermatology market today released final findings from its Phase 2a safety study of BPX01 that show the unique topical gel formulation of minocycline reduced f..

CVS Health Research Institute Study Shows Value in Tailoring Medication Adherence Interventions to Specific Patient Populations

Monday, August 22, 2016 PR Newswire

WOONSOCKET RI Aug 22 2016 PRNewswire A new study from the CVS Health Research Institute found that interventions to keep patients with common chronic conditions adherent is extraordinarily costeffective The study published today in The American Journal of Managed Care also found an even greater op..

TOP